Healthy valuation

Astorg Partners and its co-investor Goldman Sachs announced the acquisition of French pharmaceutical company HRA Pharma, specialist in women’s health and rare endocrine disorders. The transaction was led by Rothschild.

Crescendo Partners was responsible for crafting the management presentation.



Back to all news Back to main page